StockData
Belite Bio, Inc logo

Belite Bio, Inc (BLTE) stock

BLTENasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 31, 2026Score 5/30
$156.23−1.49 (-0.94%)

Close on Nov 18, 2026Market cap $6.15BP/E –Yield –

Belite Bio net income

Net income is the profit left for shareholders after every expense, interest and tax.

For fiscal 2025 it was -$77.61M. The highest annual figure on record is -$5.75M in fiscal 2020.

Annual net income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$77.61M–
FY2024Dec 31, 2024-$36.14M–
FY2023Dec 31, 2023-$31.63M–
FY2022Dec 31, 2022-$12.65M–
FY2021Dec 31, 2021-$9.67M–
FY2020Dec 31, 2020-$5.75M–

More Belite Bio figures

See a number that looks wrong?